TABLE 4-4 Studies of Hepatitis B Vaccination Rates in Injection-Drug Users



Sample; Design

Cross-sectional studies of vaccination rates

Seal et al., 2000

San Francisco, CA

135 under 30 years old, 96 at least 30 years old




Lum et al., 2008

San Francisco, CA

831 young IDUs




Kuo et al., 2004

Baltimore, MD

324 IDUs, NIDUs




Additional vaccination studies

Campbell et al., 2007

5 US cities




Cohort; vaccination protocol varied by city

Altice et al., 2005

New Haven, CT; mobile health van at SEP

134 HBV-negative IDUs




Des Jarlais et al., 2001

Anchorage, AK; New York City

AK cohort referred to clinic (350); New York City cohort offered on-site vaccination at SEP (36) + small cash incentives




Hutchinson et al., 2004

Glasgow, Scotland, prison vaccination, community assessment

In 1999, offered HBV vaccination to all inmates; surveyed new injectors (within 5 years)

Abbreviations: HBV, hepatitis B virus; IDU, injection-drug user; NIDU, non-injection-drug user; SEP, syringe-exchange program.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement